New Aerosol Formulas from California Pharmacy Help Sinus Sufferers Breathe Easier

Aerosol Science Laboratories Inc. has just released two new compounded medications, which are now available for nasal inhalation. Aerosol Science's ASL Pharmacy division has added Mupirocin (active ingredient in Bactroban®) and Mometasone (active ingredient in Nasonex®) to its extensive list of compounded antibiotic, antifungal and corticosteroid aerosolized solutions for treating sinus conditions. Unlike traditional therapies, the medications from ASL are inhaled by the patient through the nose for better medication deposition into the sinuses.

Camarillo, CA (PRWEB) June 4, 2007 -- Aerosol Science Laboratories Inc. has just released two new compounded medications, which are now available for nasal inhalation. Aerosol Science's ASL Pharmacy division has added Mupirocin (active ingredient in Bactroban®) and Mometasone (active ingredient in Nasonex®) to its extensive list of compounded antibiotic, antifungal and corticosteroid aerosolized solutions for treating sinus conditions. Unlike traditional therapies, the medications from ASL are inhaled by the patient through the nose for better medication deposition into the sinuses.

Mupirocin 3.3mg/2cc is formulated to aerosolize in approximately 5-7 minutes. Mupirocin inhalation solution represents a new class of antibiotic available to physicians to treat infections caused by staphylococcus aureus and methicillin resistant staphylococcus aureus.

Mometasone 0.6mg/2cc is formulated as a very fine suspension, which aerosolizes in approximately 4 minutes. This fast treatment time is beneficial for those patients who have been prescribed more than one medication, such as an antibiotic or an antifungal along with their corticosteroid.

Following are important benefits of inhaled sinus medications to physicians and patients:

•Most PPO insurance plans, including Medicare Part D, cover ASL Pharmacy's aerosol therapies.

•ASL Pharmacy provides quick turnaround of Rx orders, which are shipped directly to the patient.

•Physician practices are notified when new prescriptions ship.

•ASL Pharmacy's nasal nebulizer is fast, portable, and silent.

Aerosol Science Laboratories seeks opportunities to assist physicians with their PAR (Perennial Allergic Rhinitis), AFS (Allergic Fungal Sinusitis) and CRS (Chronic Rhinosinusitis patient cases. ASL's Sinus Science™ therapies provide an alternative for physicians to consider when treating sinus disorders. Because inhaled medications travel directly to the site of infection, this therapy may provide better outcomes where traditional treatments have failed, without the harmful side effects of oral or intravenous drugs.

More than three hundred physicians currently refer aerosolized prescriptions to ASL Pharmacy. With over a year of operational experience formulating sinus medications exclusively, ASL has shipped over 2,000 orders in less than 12 months. According to the Center for Disease Control, there are over 32 million cases of Chronic Sinusitis annually.

For further information, please contact Cal Tarrant at 866-552-7579 ext. 223 or visit our website at www.aslrx.com or www.sinusscience.com.

###